drugset / Trial / NCT01798251
XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach
RandomizedParallel-groupOpen-labelTreatment
Summary
To confirm the efficacy and safety of XELOX with capecitabine maintenance in treatment of elderly advanced gastric cancer (AGC) by comparing it with that of XELOX regimen.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 850 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 100 mg/m2 | Intravenous |